With this Postgraduate diploma you will be aware of the latest advances in the treatment, evaluation and diagnosis of Cutaneous Neoplasms in Onco-Hematologic Patients” 

Over time, it has been shown that immunocompromised patients, such as those undergoing bone marrow transplants or with diseases such as Leukemia, Lymphoma or Multiple Myeloma, have a higher risk of developing skin tumors due to their weakened immune status. Therefore, in response to this growing problem, the medical and scientific community has focused its efforts on the development of more effective diagnostic and therapeutic techniques to address Cutaneous Neoplasms in Onco-Hematologic Patients. For this reason, it is important for the physician to be at the forefront of these techniques, in order to offer an effective and personalized treatment to his patients.  

With this in mind, TECH has elaborated this program that will allow the specialist to enjoy an excellent overview of Cutaneous Tumors in Onco-Hematologic Patients. In a 6-month course, the expert will receive an extensive education on the epidemiology of the pathology, frequency, distribution and trends of cutaneous neoplasms in oncology patients. It will also delve into factors such as its pathogenesis, clinical presentation, histology and immunohistochemistry, and clinical and laboratory evaluations, as well as histopathological and immunohistochemical tests. 

Consequently, this Postgraduate diploma, which is offered in a 100% online format, provides the physician with the possibility of continuing with their personal and work activities along with this program, since they will not have to adhere to a specific class schedule.  

You can also access all the content available for the program from any place and at any time, since you will only need an electronic device with an Internet connection. This degree also implements the Relearningmethod, which guarantees you optimizing time and remembering the most complex concepts in less time.    

You will deepen in the classification and staging of different cutaneous tumors, to choose the most appropriate treatment route according to the pathology"

This Postgraduate diploma in Cutaneous Neoplasms in Onco-Hematologic Patients contains the most complete and up-to-date scientific program on the market. The most important features include: 

• The development of case studies presented by experts in Dermatology, Oncology and Plastic and Reconstructive Surgery
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice 
• Practical exercises where self-assessment can be used to improve learning
• Its special emphasis on innovative methodologies  
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments 
• Content that is accessible from any fixed or portable device with an Internet connection 

You will be aware of the effectiveness of Radiotherapy, Chemotherapy and Immunotherapy as the most effective treatment measures for 
most effective treatment measures for Onco-Hematologic patients” 

The program’s teaching staff includes professionals from sector who contribute their work experience to this educational program, as well as renowned specialists from leading societies and prestigious universities.  

Its multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide an immersion education programmed to learn in real situations.

The design of this program focuses on Problem-Based Learning, by means of which the professional must try to solve the different professional practice situations that are presented throughout the academic course. For this purpose, the student will be assisted by an innovative interactive video system created by renowned experts.   

With this degree you will delve into Mycosis Fungoides and Sezary Syndrome and the most up-to-date diagnostic techniques for their proper treatment” 

Thanks to TECH you will be aware of the advances in the detection of cutaneous primitive B lymphomas and cutaneous lymphomas in childhood” 

This Postgraduate diploma offers a wide range of relevant content in the field Cutaneous Neoplasms in Onco-Hematologic Patients. This way, the program provides a complete review on the evaluation of other cutaneous neoplasms, including their classification, staging and diagnosis, squamous cell carcinoma of the oral cavity and the analysis of cutaneous lymphomas. It will also delve into lymphomatoid papulosis and the epidemiology and etiopathogenesis of dermatologic pathology in oncologic patients. All this, complemented by multiple multimedia resources such as detailed video and real case studies that the professional can access at any time and place without time restrictions. 

You will experience a significant reinforcement of your previous knowledge and a faster and more effective assimilation of new information thanks to the Relearning method”

Module 1. Other Skin Neoplasms

1.1. Evaluation of other skin neoplasms

1.1.1. Classification of other skin neoplasms
1.1.2. Staging of other skin neoplasms
1.1.3. Diagnosis of other skin neoplasms

1.2. Oral cavity squamous cell carcinoma

1.2.1. Analysis of squamous cell carcinoma of the oral cavity
1.2.2. Histopathology of oral cavity squamous cell carcinoma
1.2.3. Diagnosis of oral cavity squamous cell carcinoma
1.2.4. Treatment of squamous cell carcinoma of the oral cavity

1.3. Penile squamous cell carcinoma

1.3.1. Evaluation of penile squamous cell carcinoma
1.3.2. Histopathology of penile squamous cell carcinoma
1.3.3. Diagnosis of penile squamous cell carcinoma
1.3.4. Treatment of penile squamous cell carcinoma

1.4. Anal squamous carcinoma

1.4.1. Analysis of anal squamous cell carcinoma
1.4.2. Histopathology of anal squamous cell carcinoma
1.4.3. Diagnosis of anal squamous cell carcinoma
1.4.4. Treatment of anal squamous cell carcinoma

1.5. Kaposi's Sarcoma

1.5.1. Evaluation of Kaposi's sarcoma
1.5.2. Histopathology of Kaposi's Sarcoma
1.5.3. Diagnosis of Kaposi's sarcoma
1.5.4. Treatment of Kaposi's sarcoma

1.6. Leukoplakia

1.6.1. Analysis of Leukoplakia
1.6.2. Histopathology of Leukoplakia
1.6.3. Diagnosis of Leukoplakia
1.6.4. Treatment of leukoplakia

1.7. Keratoacanthomas

1.7.1. Evaluation of Keratoacanthomas
1.7.2. Histopathology of keratoacanthomas
1.7.3. Diagnosis of Keratoacanthomas
1.7.4. Treatment of keratoacanthomas

1.8. Invasive Paget’s Disease

1.8.1. Analysis of extramammary Paget's disease
1.8.2. Histopathology of extramammary Paget's disease
1.8.3. Diagnosis of extramammary Paget disease
1.8.4. Treatment of extramammary Paget disease

1.9. Malignant subcutaneous or soft-tissue tumors (sarcomas)

1.9.1. Dermatofibrosarcoma
1.9.2. Leiomyosarcomas
1.9.3. Rhabdomyosarcoma
1.9.4. Liposarcomas

1.10. Epidermal lesions

1.10.1. Actinic Keratosis
1.10.2. Bowen's Disease
1.10.3. Spitzoid lesions

Module 2. Cutaneous Lymphomas

2.1. Skin Lymphoma Analysis

2.1.1. Skin Lymphoma Evaluation
2.1.2. Classification of skin lymphomas
2.1.3. Diagnosis of skin lymphomas
2.1.4. Treatment of skin lymphomas

2.2. Lymphomatoid Papulosis

2.2.1. Clinic in lymphomatoid papulosis
2.2.2. Histopathology in lymphomatoid papulosis
2.2.3. Staging in lymphomatoid papulosis
2.2.4. Treatment in Lymphomatoid Papulosis

2.3. Mycosis Fungoides

2.3.1. Clinic in mycosis fungoides
2.3.2. Histopathology in mycosis fungoides
2.3.3. Staging in mycosis fungoides
2.3.4. Treatment in mycosis fungoides

2.4. Sezary syndrome

2.4.1. Clinic in Sezary Syndrome
2.4.2. Histopathology in Sezary Syndrome
2.4.3. Staging in Sezary Syndrome
2.4.4. Treatment in Sezary Syndrome

2.5. Adult T leukemia

2.5.1. Clinical features in adult T leukemia
2.5.2. Histopathology in Adult T Leukemia
2.5.3. Staging in Adult T Leukemia
2.5.4. Treatment in Adult T Leukemia

2.6. Adult T-cell lymphoma

2.6.1. Clinical features of adult T-cell lymphoma
2.6.2. Histopathology in Adult T-cell lymphoma
2.6.3. Staging in Adult T-cell lymphoma
2.6.4. Treatment features of adult T-cell lymphoma

2.7. Anaplastic cutaneous large cell anaplastic lymphoma cd30+

2.7.1. Clinical features in anaplastic cutaneous large cell lymphoma cd30+
2.7.2. Histopathology in Anaplastic cutaneous large cell anaplastic lymphoma cd30+
2.7.3. Staging in Anaplastic cutaneous large cell anaplastic lymphoma cd30+
2.7.4. Treatment features in anaplastic cutaneous large cell lymphoma cd30+

2.8. Cutaneous primitive B lymphomas

2.8.1. Clinical features of cutaneous primitive B lymphomas
2.8.2. Histopathology in cutaneous primitive B-lymphomas
2.8.3. Staging in Cutaneous primitive B lymphomas
2.8.4. Treatment features of cutaneous primitive B lymphomas

2.9. Primary cutaneous lymphomas in childhood

2.9.1. Clinical features of primary cutaneous lymphomas in childhood
2.9.2. Histopathology in primary cutaneous lymphomas in infancy
2.9.3. Staging in primary cutaneous lymphomas in childhood
2.9.4. Treatment in primary cutaneous lymphomas in childhood

2.10. Follow-up and recommendations

2.10.1. Initial stage: First year
2.10.2. Follow up: Second year
2.10.3. In the Long Term
2.10.4. Recommendations

Module 3. Dermatologic Pathology in the Oncology Patient

3.1. Evaluation of dermatologic pathology in the oncology patient

3.1.1. Pathology analysis
3.1.2. Evolution of the pathology
3.1.3. Epidemiology of the pathology
3.1.4. Etiopathogenesis of the pathology

3.2. Diagnosis

3.2.1. Clinical Symptoms
3.2.2. Histology
3.2.3. Immunohistochemistry
3.2.4. Diagnosis

3.3. Skin lesions induced by conventional antineoplastic QT

3.3.1. Erythema toxicum of QT
3.3.2. Localized Epidermal Necrolysis
3.3.3. Epidermal cytotoxicity syndrome Acral erythema/ Foot-hand syndrome
3.3.4. Reactivation ("recall") reactions

3.4. Paraneoplastic dermatomyositis

3.4.1. Paraneoplastic dermatomyositis analysis
3.4.2. Paraneoplastic dermatomyositis Clinical Symptoms
3.4.3. Paraneoplastic dermatomyositis Histopathology
3.4.4. Paraneoplastic dermatomyositis Treatment

3.5. Paraneoplastic neutrophilic dermatoses

3.5.1. Evaluation of paraneoplastic neutrophilic dermatoses
3.5.2. Clinical signs of paraneoplastic neutrophilic dermatosis
3.5.3. Histopathology of paraneoplastic neutrophilic dermatoses
3.5.4. Treatment of paraneoplastic neutrophilic dermatoses

3.6. Graft-versus-host disease

3.6.1. Analysis of graft-versus-host disease
3.6.2. Clinical Symptoms of Graft-Versus-Host Disease (GVHD)
3.6.3. Histopathology of Graft-Versus-Host Disease (GVHD)
3.6.4. Treatment of graft-versus-host disease

3.7. Paraneoplastic pemphigus

3.7.1. Evaluation of paraneoplastic pemphigus
3.7.2. Clinical manifestations of paraneoplastic pemphigus
3.7.3. Histopathology of paraneoplastic pemphigus
3.7.4. Treatment of paraneoplastic pemphigus

3.8. Skin infections of dermatological interest in oncology patients

3.8.1. Analysis of skin infections
3.8.2. Clinic of skin infections
3.8.3. Histopathology of skin infections
3.8.4. Treatment of skin infections

3.9. Cutaneous metastases of systemic neoplasms

3.9.1. Analysis of metastasis of systemic neoplasms
3.9.2. Clinical Symptoms of metastasis of systemic neoplasms
3.9.3. Histopathology of metastasis of systemic neoplasms
3.9.4. Treatment of metastasis of systemic neoplasms

3.10. Cutaneous Manifestations of Malignant Neoplasms

3.10.1. Evolution of Cutaneous Manifestations of Malignant Neoplasms
3.10.2. Clinical Manifestations of Cutaneous Manifestations of Malignant Neoplasms
3.10.3. Histopathology of Cutaneous Manifestations of Malignant Neoplasms
3.10.4. Treatment of Cutaneous Manifestations of Malignant Neoplasms

With this degree you will be aware of  the latest strategies for the management of paraneoplastic pemphigus and other skin conditions related to malignant neoplasms”